Profile
Mr. M.
D.
Winship is Vice President-Regulatory Operations at Catalyst Pharmaceutical Partners, Inc.
Mr. Winship was previously employed as VP-Quality Assurance & Regulatory Affairs by Argos Therapeutics, Inc., SVP-Regulatory Affairs & Quality Assurance by CEL-SCI Corp., and VP-Regulatory Affairs & Quality Assurance by Curative Technologies, Inc.
He received his undergraduate degree from Upsala College.
Former positions of M. Douglas Winship
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | General Counsel | 2004-12-31 |
| CEL-SCI CORPORATION | General Counsel | 2001-12-31 |
Curative Technologies, Inc.
 Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Curative Technologies, Inc. is an American biopharmaceutical research company. | General Counsel | 1993-12-31 |
| CATALYST PHARMACEUTICALS, INC. | General Counsel | - |
Training of M. Douglas Winship
| Upsala College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CEL-SCI CORPORATION | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Curative Technologies, Inc.
Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Curative Technologies, Inc. is an American biopharmaceutical research company. | Commercial Services |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- M. Douglas Winship
